MétaCan
Menu
Back to cohort
Record W4210298192 · doi:10.1016/j.esmoop.2022.100403

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

2022· article· en· W4210298192 on OpenAlexfundno aff
Christian Buske, Martin Dreyling, Alberto Álvarez‐Larrán, J. Apperley, Luca Arcaini, Caroline Besson, Lars Bullinger, Paolo Corradini, Matteo Giovanni Della Porta, Meletios Α. Dimopoulos, Shirley D’Sa, H.T. Eich, R. Foà, Paolo Ghia, María Gomes da Silva, John G. Gribben, Roman Hájek, Conrad Harrison, M. Heuser, Barbara Kiesewetter, Jean‐Jacques Kiladjian, Nicolaus Kröger, P. Moreau, Jakob Passweg, Flora Peyvandi, Delphine Réa, Josep‐María Ribera, Tadeusz Robak, Jesús F. San Miguel, Valeria Santini, Guillermo Sanz, Pieter Sonneveld, Marie von Lilienfeld‐Toal, Clemens‐Martin Wendtner, George Pentheroudakis, Francesco Passamonti

Bibliographic record

VenueESMO Open · 2022
Typearticle
Languageen
FieldMedicine
TopicCOVID-19 and healthcare impacts
Canadian institutionsnot available
FundersCilagJanssen PharmaceuticalsChugai PharmaceuticalAstraZenecaGenentechMorphoSysPharmaMarDaiichi Sankyo EuropeEuropean Society for Medical OncologyDeutsche KrebshilfePfizerJosé Carreras Leukämie-StiftungShionogiBritish Society for HaematologyNational Institute for Health and Care ResearchBayerAstellas PharmaCelltrionSkylineDxSanofi-Aventis DeutschlandBeiGeneSanofiTG TherapeuticsMedacIpsenJazz PharmaceuticalsRegeneron PharmaceuticalsMeso Scale DiagnosticsHelsinnTakeda Pharmaceutical CompanyNovartis PharmaAbbVieAOP OrphanBundesministerium für Bildung und ForschungEUSA PharmaMerck KGaAIncyteServierGilead SciencesCelgeneNovartisGlaxoSmithKlineEli Lilly and CompanyBristol-Myers SquibbDeutsche ForschungsgemeinschaftRocheSierra OncologyGalectoAstellas Pharma USBoehringer IngelheimAmgen
KeywordsPandemicCoronavirus disease 2019 (COVID-19)MedicineConsensus conferenceMEDLINEFamily medicine2019-20 coronavirus outbreakIntensive care medicinePolitical scienceInternal medicinePathologyDiseaseLaw

Abstract

fetched live from OpenAlex

BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.091
metaresearch head score (Gemma)0.102
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.091
Threshold uncertainty score0.480

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0910.102
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0030.002
Science and technology studies0.0040.003
Scholarly communication0.0050.005
Open science0.0040.012
Research integrity0.0120.013
Insufficient payload (model declined to judge)0.0060.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.155
GPT teacher head0.477
Teacher spread0.322 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations58
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueESMO OpenSame topicCOVID-19 and healthcare impactsFrench-language works237,207